Frenalytics Accepted into Prestigious MassChallenge’s 2022 Early Stage Accelerator Program


by | July 11, 2022


BOSTON, MA, July 11, 2022 –– Frenalytics’ CEO & co-founder Matt Giovanniello today announced that the patented cognitive therapy startup has been accepted into MassChallenge’s 2022 Early Stage Accelerator Program.


MassChallenge, headquartered in Boston with offices globally, runs a series of competitive, worldwide accelerators for early-stage startups such as Frenalytics, which aims to introduce and support long-term partner and client relationships for the organizations that make the cut into their annual Early Stage Accelerator Program. Frenalytics was selected among thousands of applications from startups around the world.


For Frenalytics, which provides personalized, interactive learning tools for cognitively impaired patients and students with special needs, MassChallenge’s seal of approval is its latest official recognition from one of many leading organizations in the technology, health, and education spaces.


“This is incredibly exciting – I see this as the beginning of many fruitful relationships with MassChallenge’s sponsors and partners,” said Matt Giovanniello, CEO and co-founder of Frenalytics. “With MassChallenge’s help, we anticipate our work on behalf of people with developmental disabilities and students enrolled in special education programs, as well as the many thousands of senior citizens tackling memory and cognitive challenges, to be made more widely available and even more effective.”

“MassChallenge will help facilitate broader reach, as we’ll be able to collaborate with their partners – Boston Children’s Hospital, Boston University, City of Boston, Massachusetts Department of Developmental Services, US Department of Health and Human Services, and Massachusetts Executive Office of Elder Affairs, among others – to improve the Frenalytics software, introduce our platform to more patients and students, and help us grow into new markets,” remarked David Campanelli, Director of Marketing for Frenalytics.


Matt, a graduate of Boston College, was inspired to create the original version of Frenalytics after his grandmother suffered a massive stroke when he was 12 years old. Today, Frenalytics has grown to diverse offerings to meet diverse needs – including FrenalyticsMED as cognitive therapy and FrenalyticsEDU for personalized classroom learning – and has partnered with EdTech startup IEP&Me to revolutionize the individualized education program (IEP) process through data-rich IEPs and personalized lessons based on IEP goals.


With the support and backing of MassChallenge, Frenalytics is now poised to bring the benefits of effective and engaging, interactive digital learning to diverse segments of the Greater Boston area population and around the world.


Engage Your Mind™ with Frenalytics – signup for a free trial, or call (516) 399-7170 to learn more.


About Frenalytics
Frenalytics is a patented, cloud-based interactive platform that offers personalized learning sessions for patients and students with cognitive deficits. The first version of Frenalytics was created by CEO Matt after his grandmother suffered a massive stroke during open-heart surgery. With Frenalytics, clinicians, teachers, and family members are directly involved in their patient’s or student’s care to make (re)learning fun and engaging from virtually anywhere.

Want to see how Frenalytics helps patients and students live more independent lives?
Click here to learn more, or give us a call at (516) 399-7170.

Try Frenalytics for free!

Leave a Reply

Your email address will not be published.